Resources

Type of publications
Regions
Diseases

5253 results found

2013 ∙ Salleras, L. Navas, E. Torner, N. Prat, A. A. Garrido, P. Soldevila, N. Domínguez, A.

Economic benefits of inactivated influenza vaccines in the prevention of seasonal influenza in children

  • Newborn
  • Children
  • Adolescents
  • Influenza
  • Efficacy/effectiveness
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2013 ∙ Unim, B. Saulle, R. Boccalini, S. Taddei, C. Ceccherini, V. Boccia, A. Bonanni, P. La Torre, G.

Economic evaluation of varicella vaccination : Results of a systematic review

  • Newborn
  • Children
  • Adults
  • Healthcare workers
  • Varicella
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2013 ∙ Schönberger, K. Kirchgässner, K. Riedel, C. von Kries, R.

Effectiveness of 2+1 PCV7 vaccination schedules in children under 2 years: A meta-analysis of impact studies

  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2013 ∙ Jackson, C. Mann, A. Mangtani, P. Fine, P.

Effectiveness of haemophilus influenzae type b vaccines administered according to various schedules: Systematic review and meta-analysis of observational data

  • Newborn
  • Haemophilus influenzae type B
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2013 ∙ Lukšić, I. Clay, S. Falconer, R. Pulanić, D. Rudan, I. Campbell, H. Nair, H.

Effectiveness of seasonal influenza vaccines in children - A systematic review and metaanalysis

  • Newborn
  • Children
  • Adolescents
  • Influenza
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2013 ∙ Gotuzzo, E. Yactayo, S. Cordova, E.

Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years

  • Newborn
  • Children
  • Pregnant women
  • Travellers
  • Yellow fever
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2013 ∙ Breteler, J. K. Tam, J. S. Jit, M. Ket, J. C. De Boer, M. R.

Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: a systematic review and meta-analysis

  • All age groups
  • Low and Middle Income Countries
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2013 ∙ Bassani, D. G. Arora, P. Wazny, K. Gaffey, M. F. Lenters, L. Bhutta, Z. A.

Financial incentives and coverage of child health interventions: a systematic review and meta-analysis

  • Newborn
  • Children
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2013 ∙ Babigumira, J. B. Morgan, I. Levin, A.

Health economics of rubella: a systematic review to assess the value of rubella vaccination

  • All age groups
  • Healthcare workers
  • Pregnant women
  • Rubella
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2013 ∙ Thomas, R. E. Spragins, W. Lorenzetti, D. L.

How many published cases of serious adverse events after yellow fever vaccination meet Brighton Collaboration diagnostic criteria?

  • All age groups
  • Yellow fever
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...